{"id":"https://openalex.org/W3192409202","doi":"https://doi.org/10.1016/s1470-2045(21)00419-8","title":"Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma \u2013 Authors' reply","display_name":"Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma \u2013 Authors' reply","publication_year":2021,"publication_date":"2021-07-30","ids":{"openalex":"https://openalex.org/W3192409202","doi":"https://doi.org/10.1016/s1470-2045(21)00419-8","mag":"3192409202","pmid":"https://pubmed.ncbi.nlm.nih.gov/34339647"},"language":"en","primary_location":{"id":"doi:10.1016/s1470-2045(21)00419-8","doi":"https://doi.org/10.1016/s1470-2045(21)00419-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1470-2045(21)00419-8","pdf_url":null,"source":{"id":"https://openalex.org/S116900674","display_name":"The Lancet Oncology","issn_l":"1470-2045","issn":["1470-2045","1474-5488"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Oncology","raw_type":"journal-article"},"volume":null,"type":"letter","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059961435","display_name":"In\u00eas Pires da Silva","orcid":"https://orcid.org/0000-0003-3540-8906","observed_orcids":["https://orcid.org/0000-0003-3540-8906"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Ines Pires da Silva","raw_affiliation_strings":["Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Department of Medical Oncology, Westmead and Blacktown Hospitals, Sydney, NSW, Australia","Department of Medical Oncology, Westmead and Blacktown Hospitals, Sydney, NSW, Australia","Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Department of Medical Oncology, Westmead and Blacktown Hospitals, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2803024705","https://openalex.org/I4210118383"]},{"raw_affiliation_string":"Department of Medical Oncology, Westmead and Blacktown Hospitals, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I2803024705"]},{"raw_affiliation_string":"Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I4210118383"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036987287","display_name":"Tasnia Ahmed","orcid":"https://orcid.org/0000-0001-7969-6335","observed_orcids":["https://orcid.org/0000-0001-7969-6335"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Tasnia Ahmed","raw_affiliation_strings":["Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I4210118383"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022668182","display_name":"Irene L. M. Reijers","orcid":"https://orcid.org/0000-0002-7103-3219","observed_orcids":["https://orcid.org/0000-0002-7103-3219"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Irene L M Reijers","raw_affiliation_strings":["The Netherlands Cancer Institute, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Netherlands Cancer Institute, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071144743","display_name":"Allison Betof Warner","orcid":"https://orcid.org/0000-0001-6422-2997","observed_orcids":["https://orcid.org/0000-0001-6422-2997"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allison Betof Warner","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038759671","display_name":"James Randall Patrinely","orcid":"https://orcid.org/0000-0002-0979-1625","observed_orcids":["https://orcid.org/0000-0002-0979-1625"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Randall Patrinely","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013399740","display_name":"Patricio Serra-Bellver","orcid":"https://orcid.org/0000-0003-2664-902X","observed_orcids":["https://orcid.org/0000-0003-2664-902X"]},"institutions":[{"id":"https://openalex.org/I125671874","display_name":"National Health Service","ror":"https://ror.org/02wnqcb97","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I125671874","https://openalex.org/I1311074006"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Patricio Serra-Bellver","raw_affiliation_strings":["Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK","institution_ids":["https://openalex.org/I125671874","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065819179","display_name":"Clara Allayous","orcid":"https://orcid.org/0000-0002-1762-152X","observed_orcids":["https://orcid.org/0000-0002-1762-152X"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I204730241","display_name":"Universit\u00e9 Paris Cit\u00e9","ror":"https://ror.org/05f82e368","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]},{"id":"https://openalex.org/I4387154437","display_name":"HIPI -  Immunologie humaine, physiopathologie et immunith\u00e9rapie","ror":"https://ror.org/008e1sp22","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4387154437"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Clara Allayous","raw_affiliation_strings":["AP-HP Dermatology, INSERM U976, Universit\u00e9 de Paris, Saint Louis Hospital, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AP-HP Dermatology, INSERM U976, Universit\u00e9 de Paris, Saint Louis Hospital, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210097159","https://openalex.org/I4210144610","https://openalex.org/I4387154437"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082278497","display_name":"Joanna Mangana","orcid":"https://orcid.org/0000-0003-3962-7575","observed_orcids":["https://orcid.org/0000-0003-3962-7575"]},"institutions":[{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Joanna Mangana","raw_affiliation_strings":["Department of Dermatology, University Hospital Zurich, Zurich, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, University Hospital Zurich, Zurich, Switzerland","institution_ids":["https://openalex.org/I4210100468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064923908","display_name":"Lisa Zimmer","orcid":"https://orcid.org/0000-0002-3680-3521","observed_orcids":["https://orcid.org/0000-0002-3680-3521"]},"institutions":[{"id":"https://openalex.org/I4210119759","display_name":"Essen University Hospital","ror":"https://ror.org/02na8dn90","country_code":"DE","type":"funder","lineage":["https://openalex.org/I4210119759"]},{"id":"https://openalex.org/I62318514","display_name":"University of Duisburg-Essen","ror":"https://ror.org/04mz5ra38","country_code":"DE","type":"education","lineage":["https://openalex.org/I62318514"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Lisa Zimmer","raw_affiliation_strings":["Department of Dermatology, University Hospital Essen, University Duisburg-Essen, Essen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, University Hospital Essen, University Duisburg-Essen, Essen, Germany","institution_ids":["https://openalex.org/I4210119759","https://openalex.org/I62318514"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017778536","display_name":"Claudia Trojaniello","orcid":"https://orcid.org/0000-0002-5677-5679","observed_orcids":["https://orcid.org/0000-0002-5677-5679"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Claudia Trojaniello","raw_affiliation_strings":["Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Napoli, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Napoli, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052403208","display_name":"Oliver Klein","orcid":"https://orcid.org/0000-0003-0022-9553","observed_orcids":["https://orcid.org/0000-0003-0022-9553"]},"institutions":[{"id":"https://openalex.org/I4405265871","display_name":"Olivia Newton-John Cancer Research Institute","ror":"https://ror.org/05yncf830","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I196829312","https://openalex.org/I4210158799","https://openalex.org/I4405265871"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Oliver Klein","raw_affiliation_strings":["Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia","institution_ids":["https://openalex.org/I4405265871"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050031536","display_name":"Camille Lea Gerard","orcid":"https://orcid.org/0000-0002-6007-1746","observed_orcids":["https://orcid.org/0000-0002-6007-1746"]},"institutions":[{"id":"https://openalex.org/I2802229882","display_name":"Centre Hospitalier Universitaire Vaudois","ror":"https://ror.org/05a353079","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802229882"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Camille L Gerard","raw_affiliation_strings":["Oncology Department, Lausanne University Hospital, Lausanne, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Department, Lausanne University Hospital, Lausanne, Switzerland","institution_ids":["https://openalex.org/I2802229882"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009968141","display_name":"Olivier Alain Michielin","orcid":"https://orcid.org/0000-0003-4926-6355","observed_orcids":["https://orcid.org/0000-0003-4926-6355"]},"institutions":[{"id":"https://openalex.org/I2802229882","display_name":"Centre Hospitalier Universitaire Vaudois","ror":"https://ror.org/05a353079","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802229882"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Olivier Michielin","raw_affiliation_strings":["Oncology Department, Lausanne University Hospital, Lausanne, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Department, Lausanne University Hospital, Lausanne, Switzerland","institution_ids":["https://openalex.org/I2802229882"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090545021","display_name":"Andrew Mark Haydon","orcid":"https://orcid.org/0000-0002-4631-5855","observed_orcids":["https://orcid.org/0000-0002-4631-5855"]},"institutions":[{"id":"https://openalex.org/I2801993434","display_name":"The Alfred Hospital","ror":"https://ror.org/01wddqe20","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2801993434","https://openalex.org/I4210163178"]},{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Andrew Haydon","raw_affiliation_strings":["Department of Medical Oncology, Alfred Hospital, Monash University, Melbourne, VIC, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Alfred Hospital, Monash University, Melbourne, VIC, Australia","institution_ids":["https://openalex.org/I2801993434","https://openalex.org/I56590836"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029398339","display_name":"Paolo A. Ascierto","orcid":"https://orcid.org/0000-0002-8322-475X","observed_orcids":["https://orcid.org/0000-0002-8322-475X"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Paolo A Ascierto","raw_affiliation_strings":["Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Napoli, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Napoli, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083061830","display_name":"Matteo Salvatore Carlino","orcid":"https://orcid.org/0000-0002-7861-4104","observed_orcids":["https://orcid.org/0000-0002-7861-4104"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Matteo S Carlino","raw_affiliation_strings":["Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Department of Medical Oncology, Westmead and Blacktown Hospitals, Sydney, NSW, Australia","Department of Medical Oncology, Westmead and Blacktown Hospitals, Sydney, NSW, Australia","Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Department of Medical Oncology, Westmead and Blacktown Hospitals, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2803024705","https://openalex.org/I4210118383"]},{"raw_affiliation_string":"Department of Medical Oncology, Westmead and Blacktown Hospitals, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I2803024705"]},{"raw_affiliation_string":"Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I4210118383"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025478490","display_name":"C\u00e9l\u00e8ste Lebb\u00e9","orcid":"https://orcid.org/0000-0002-5854-7290","observed_orcids":["https://orcid.org/0000-0002-5854-7290"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I204730241","display_name":"Universit\u00e9 Paris Cit\u00e9","ror":"https://ror.org/05f82e368","country_code":"FR","type":"education","lineage":["https://openalex.org/I204730241"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210144610","display_name":"H\u00f4pital Saint-Louis","ror":"https://ror.org/049am9t04","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210144610"]},{"id":"https://openalex.org/I4387154437","display_name":"HIPI -  Immunologie humaine, physiopathologie et immunith\u00e9rapie","ror":"https://ror.org/008e1sp22","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4387154437"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Celeste Lebbe","raw_affiliation_strings":["AP-HP Dermatology, INSERM U976, Universit\u00e9 de Paris, Saint Louis Hospital, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AP-HP Dermatology, INSERM U976, Universit\u00e9 de Paris, Saint Louis Hospital, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I204730241","https://openalex.org/I4210097159","https://openalex.org/I4210144610","https://openalex.org/I4387154437"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069095893","display_name":"Paul C. Lorigan","orcid":"https://orcid.org/0000-0002-8875-2164","observed_orcids":["https://orcid.org/0000-0002-8875-2164"]},"institutions":[{"id":"https://openalex.org/I125671874","display_name":"National Health Service","ror":"https://ror.org/02wnqcb97","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I125671874","https://openalex.org/I1311074006"]},{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paul Lorigan","raw_affiliation_strings":["Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Services, The University of Manchester, Manchester, UK","Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK","Division of Cancer Services, The University of Manchester, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Services, The University of Manchester, Manchester, UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210133995"]},{"raw_affiliation_string":"Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK","institution_ids":["https://openalex.org/I125671874","https://openalex.org/I4210133995"]},{"raw_affiliation_string":"Division of Cancer Services, The University of Manchester, Manchester, UK","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025067315","display_name":"Douglas Buckner Johnson","orcid":"https://orcid.org/0000-0002-6390-773X","observed_orcids":["https://orcid.org/0000-0002-6390-773X"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas B Johnson","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064026461","display_name":"Shahneen Kaur Sandhu","orcid":"https://orcid.org/0000-0002-8660-4475","observed_orcids":["https://orcid.org/0000-0002-8660-4475"]},"institutions":[{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Shahneen Sandhu","raw_affiliation_strings":["Peter MacCallum Cancer Centre, Melbourne, VIC, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Peter MacCallum Cancer Centre, Melbourne, VIC, Australia","institution_ids":["https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040969461","display_name":"Serigne Lo","orcid":"https://orcid.org/0000-0001-5092-5544","observed_orcids":["https://orcid.org/0000-0001-5092-5544"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Serigne N Lo","raw_affiliation_strings":["Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I4210118383"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022520811","display_name":"Alexander Maxwell Menzies","orcid":"https://orcid.org/0000-0001-5183-7562","observed_orcids":["https://orcid.org/0000-0001-5183-7562"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2800079252","display_name":"Royal North Shore Hospital","ror":"https://ror.org/02gs2e959","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800079252"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Alexander M Menzies","raw_affiliation_strings":["Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia","Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia","Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2800079252","https://openalex.org/I4210118383"]},{"raw_affiliation_string":"Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I2800079252"]},{"raw_affiliation_string":"Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I4210118383"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070576000","display_name":"Georgina Venetia Long","orcid":"https://orcid.org/0000-0001-8894-3545","observed_orcids":["https://orcid.org/0000-0001-8894-3545"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2800079252","display_name":"Royal North Shore Hospital","ror":"https://ror.org/02gs2e959","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800079252"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Georgina V Long","raw_affiliation_strings":["Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia. Electronic address: georgina.long@melanoma.org.au","Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia","Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia. Electronic address: georgina.long@melanoma.org.au","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I4210118383"]},{"raw_affiliation_string":"Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I2800079252"]},{"raw_affiliation_string":"Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I4210118383"]}]}],"institutions":[],"countries_distinct_count":8,"institutions_distinct_count":24,"corresponding_author_ids":["https://openalex.org/A5070576000"],"corresponding_institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2800079252","https://openalex.org/I4210118383"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"22","issue":"8","first_page":"e343","last_page":"e344"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.9869999885559082},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.8899999856948853},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9449999928474426},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7170000076293945},{"id":"https://openalex.org/keywords/ecog-performance-status","display_name":"ECOG performance status","score":0.9160000085830688},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8650000095367432},{"id":"https://openalex.org/keywords/second-line-immunotherapy","display_name":"second-line immunotherapy","score":0.7950000166893005},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.9150000214576721},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9520000219345093},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.800000011920929},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.6549999713897705},{"id":"https://openalex.org/keywords/multivariable-analysis","display_name":"multivariable analysis","score":0.5699999928474426},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.578000009059906}],"concepts":[{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.9826472997665405},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8342397212982178},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.7388603091239929},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6854528784751892},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.61982661485672},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.5985986590385437},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5801555514335632},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5158693194389343},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.48191097378730774},{"id":"https://openalex.org/C77350462","wikidata":"https://www.wikidata.org/wiki/Q1125472","display_name":"Confounding","level":2,"score":0.45104220509529114},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.43837660551071167},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.4291326403617859},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.25918883085250854},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.15027913451194763},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.0684901773929596}],"mesh":[{"descriptor_ui":"D000074324","descriptor_name":"Ipilimumab","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000077594","descriptor_name":"Nivolumab","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1016/s1470-2045(21)00419-8","doi":"https://doi.org/10.1016/s1470-2045(21)00419-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1470-2045(21)00419-8","pdf_url":null,"source":{"id":"https://openalex.org/S116900674","display_name":"The Lancet Oncology","issn_l":"1470-2045","issn":["1470-2045","1474-5488"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Oncology","raw_type":"journal-article"},{"id":"pmid:34339647","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34339647","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet. Oncology","raw_type":"Letter"},{"id":"pmh:oai:unige.ch:aou:unige:191584","doi":null,"is_oa":false,"landing_page_url":"https://archive-ouverte.unige.ch/unige:191584","pdf_url":null,"source":{"id":"https://openalex.org/S4306402259","display_name":"Archive ouverte UNIGE (University of Geneva)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114457229","host_organization_name":"University of Geneva","host_organization_lineage":["https://openalex.org/I114457229"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lancet oncology, vol. 22, no. 8 (2021) p. e343-e344","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:iris.unil.ch:iris/217828","doi":null,"is_oa":false,"landing_page_url":"https://iris.unil.ch/handle/iris/217828","pdf_url":null,"source":{"id":"https://openalex.org/S7407055444","display_name":"IRIS","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"letter to the editor"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/a7420215-2736-47d8-b201-1e496ac5b3e8","doi":null,"is_oa":false,"landing_page_url":"https://research.manchester.ac.uk/en/publications/a7420215-2736-47d8-b201-1e496ac5b3e8","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"da Silva, I P, Ahmed, T, Reijers, I L M, Warner, A B, Patrinely, J R, Serra-Bellver, P, Allayous, C, Mangana, J, Zimmer, L, Trojaniello, C, Klein, O, Gerard, C L, Michielin, O, Haydon, A, Ascierto, P A, Carlino, M S, Lebbe, C, Lorigan, P, Johnson, D B, Sandhu, S, Lo, S N, Menzies, A M & Long, G V 2021, 'Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma \u2013 Authors' reply', The Lancet Oncology, vol. 22, no. 8, pp. e343-e344. https://doi.org/10.1016/S1470-2045(21)00419-8","raw_type":"info:eu-repo/semantics/publishedVersion"},{"id":"pmh:oai:serval.unil.ch:BIB_D51407044D20","doi":null,"is_oa":false,"landing_page_url":"https://serval.unil.ch/notice/serval:BIB_D51407044D20","pdf_url":null,"source":{"id":"https://openalex.org/S4306401797","display_name":"SERVAL (Universit\u00e9 de Lausanne)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210093590","host_organization_name":"Swiss School of Archaeology in Greece","host_organization_lineage":["https://openalex.org/I4210093590"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The Lancet. Oncology, vol. 22, no. 8, pp. e343-e344","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1904369736","https://openalex.org/W2151180605","https://openalex.org/W2551317550","https://openalex.org/W2753432434","https://openalex.org/W2885140428","https://openalex.org/W3043703771","https://openalex.org/W3163284774"],"related_works":["https://openalex.org/W3188961350","https://openalex.org/W3163284774","https://openalex.org/W2324811517","https://openalex.org/W3154605418","https://openalex.org/W3032544449","https://openalex.org/W2978968508","https://openalex.org/W3035324474","https://openalex.org/W2412066711","https://openalex.org/W2926751463","https://openalex.org/W4282980622"],"abstract_inverted_index":null,"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-08-16T00:00:00"}